Skip to main content

Table 1 Overview of clinical features of newly diagnosed anti-NMDA receptor encephalitis patients with a long-term history of mental disorders

From: Clinical characteristics of anti-N-methyl-d-aspartate receptor encephalitis in patients with a long-term history of mental disorders

No.

Age/sex

Initial visit

Psychiatric history (years)

Malignancies

CNS symptoms

NMDA receptor IgG

Neuroimaging

References

1

28/M

Psychiatry clinic

Major depressive disorder (12)

No

Fever, confusion, abnormal behaviors, catatonia, rigidity, seizures, speech impairment, agitation, tachycardia and anorexia

Serum: (−)

CT: no significant abnormality

Our case

CSF: (1:1)

2

52/F

Psychiatry clinic

Major depressive disorder (6)

Cervical cancer

Confusion, delusions, hallucinations, abnormal behaviors, speech impairment, and exacerbated depressed mood

Serum: ns

MRI: several small ischemic foci in frontal lobes

Rong et al. [7]

CSF(1:100)

3

52/M

Psychiatry clinic

Major depressive disorder (22)

No

Fever, seizures, insomnia, hallucinations, abnormal behaviors, poor cognition, speech impairment, tachycardia, hypopiesia and exacerbated depressed mood

Serum: (+)

MRI: no significant abnormality

Torgovnick et al. [8]

CSF: (+)

4

19/F

ns

Depressive disorders (1)

No

Headache, delusions, rigidity, insomnia, catatonia, papilledema, apathy and anorexia

Serum: ns

MRI: dural thickening and meningeal contrast enhancement

Caglayan et al. [9]

CSF: (1:100)

5

34/F

Psychiatry clinic

Bipolar disorder (10)

No

Fever, abnormal behaviors, speech impairment, catatonia, hallucinations, seizure, tachycardia, impaired memory, and orofacial dyskinesia

Serum: (+)

MRI: no significant abnormality

Simabukuro et al. [10]

CSF: (+)

6

52/F

Emergency

Bipolar disorder (8)

No

Speech impairment, rigidity, catatonia, urinary incontinence, apathy, ataxia, and dyskinesia

Serum: ns

MRI: frontoparietal cortical atrophy

Hanagasi et al. [11]

CSF: (+)

7

47/F

Psychiatry clinic

Bipolar disorder (4)

No

Aggression, catatonia, violence, anorexia, altered consciousness, stupor, and negativism

Serum: ns

MRI: no significant abnormality

Yoshimura et al. [12]

CSF: (+)

8

48/F

ns

Schizoaffective disorder (19)

No

Confusion, hallucinations, catatonia, abnormal behaviors, excitement, negativism, and stupor

Serum: ns

MRI: no significant abnormality

Yoshimura et al. [12]

CSF: (+)

9

38/F

Psychiatry clinic

Schizoaffective disorder (14)

No

Fever, confusion, speech impairment, hallucinations, seizures, insomnia, catatonia, memory impairment, agitation, and impaired attention

Serum: (+)

MRI: no significant abnormality

Heekin et al. [13]

CSF: ns

10

25/F

Psychiatry clinic

Schizophrenia (7)

No

Confusion, rigidity, insomnia, abnormal behaviors, speech impairment, delusions, dyskinesia, aggressiveness, and memory impairment

Serum: ns

MRI: a small ischemic focus in the frontal lobe

Huang et al. [14]

CSF: (+)

11

25/F

Psychiatry clinic

Schizophrenia (4)

No

Fever, tachycardia, abnormal behaviors, speech impairment, catatonia, agitation, rigidity, rhythmic orofacial grimacing, and autonomic instability

Serum: (1:640)

MRI: no significant abnormality

Conroy et al. [15]

CSF: (1:160)

12

33/M

Emergency

Schizophrenia (6)

No

Headache, rigidity, abnormal behaviors, speech impairment, catatonia, seizures, hallucinations, delusions, insomnia, psychomotor agitation, catatonic symptoms, and memory deficits

Serum: ns

MRI: no new changes compared with previous lesions

Ponte et al. [16]

CSF: (+)

13

16/F

Psychiatry clinic

Attention deficit hyperactivity disorder (4)

No

Confusion, abnormal behaviors, speech impairment, tachycardia, perceptual disturbances, and left facial droop

Serum: (1:10)

MRI: no significant abnormality

Fields et al. [17]

CSF: (1:5)

14

23/F

ns

Autism spectrum disorder (20)

Ovarian teratoma

Aggressiveness, dyskinesia and altered consciousness

Serum: (+)

MRI: no significant abnormality

Kurita et al. [18]

CSF: (+)

  1. M, male; F, female; ns, no statement; CNS, central nervous system; NMDA, N-methyl-d-aspartate; CSF, cerebrospinal fluid; +, positive